HDL Cholesterol Measurement Using Selective Aggregation Reagents

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for measuring HDL cholesterol are inefficient, time-consuming, and prone to inaccuracy due to complications in separation processes and potential for nonspecific reactions or incomplete cholesterol elimination.

Innovation Solution

A method involving cholesterol esterase and cholesterol oxidase or dehydrogenase in the presence of specific nitrogen-containing surfactants and polyanions, such as dextran sulfate, to specifically target HDL cholesterol, avoiding aggregation or elimination of other lipoproteins, thereby enabling accurate measurement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional fractionation methods (ultracentrifugation, immunochemical method, electrophoresis, precipitation) are used to separate HDL from other lipoproteins, then measurement specificity is improved, but operation complexity and time consumption increase significantly

Engineering Contradiction:
ImproveHDL cholesterol measurement specificityVSAvoidseparation operation complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates only the interfering component (non-HDL cholesterol) from the sample using selective aggregation reagents, rather than performing complex separation to isolate HDL. By removing VLDL and LDL through aggregation with dextran sulfate and other reagents, the method directly obtains measurable HDL cholesterol without requiring ultracentrifugation, electrophoresis, or other complex fractionation procedures

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces intermediary substances (aggregation reagents including dextran sulfate, divalent metal salts, and specific surfactants) that mediate the selective aggregation of non-HDL lipoproteins. These intermediaries facilitate the separation process by causing VLDL and LDL to aggregate and precipitate, allowing HDL to remain in solution for direct enzymatic measurement without complex instrumentation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional fractionation methods are used, then measurement accuracy is improved, but measurement time increases

Engineering Contradiction:
ImproveHDL cholesterol measurement accuracyVSAvoidmeasurement time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention performs preliminary selective aggregation of non-HDL lipoproteins in a single reaction step before measurement, eliminating the need for time-consuming sequential separation procedures. The aggregation reagents are added directly to the sample and allowed to act for a brief period, pre-concentrating and removing interfering substances before enzymatic measurement begins

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention merges multiple functions into a single reaction system: selective aggregation of non-HDL lipoproteins, clarification of supernatant, and enzymatic measurement of HDL cholesterol all occur in one integrated process. This combines what would traditionally require separate ultracentrifugation, decanting, and measurement steps into a single test tube reaction

Inventive Principle:
Principle #5Merging (Combining)

3Ease of operation

If aggregation reagents are used to eliminate non-HDL cholesterol, then measurement simplicity is improved, but turbidity and deposition problems occur

Engineering Contradiction:
Improvemeasurement procedure simplicityVSAvoidturbidity and deposition interference
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The invention optimizes reaction parameters including pH, temperature, and reagent concentrations to control the aggregation process. By adjusting these parameters, the method achieves complete aggregation of non-HDL lipoproteins while minimizing turbidity interference and preventing excessive deposition that could clog measurement systems or interfere with optical detection

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for simple and accurate measurement of HDL cholesterol without the need for complex separation steps, reducing measurement time and improving specificity, thus enhancing diagnostic capabilities for arteriosclerosis prediction.

Implementation Method 1

reacting the sample with i) cholesterol esterase and cholesterol oxidase or ii) cholesterol esterase, oxidized coenzyme and cholesterol dehydrogenase

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

cholesterol oxidase or dehydrogenase in the presence of specific nitrogen-containing surfactants and polyanions

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

specific nitrogen-containing surfactants and polyanions, such as dextran sulfate

Methodology Applied
Scientific EffectSurfactant action: Surfactant

Implementation Method 4

forming a complex with lipoproteins other than HDL

Methodology Applied
Scientific EffectComplex formation:

Data Source

PatentEP1876243B1Method for determination of cholesterol in high-density lipoprotein
Publication Date: 2012.10.17 KYOWA MEDEX CO LTD
  • EP1876243B1 patent drawing
  • EP1876243B1 patent drawing
  • EP1876243B1 patent drawing

AI summary

The present invention provides a reagent, a reagent and a kit for the simple and accurate measurement of HDL cholesterol. The method for the measurement of cholesterol in high-density lipoprotein in a sample comprises reacting the sample with i) cholesterol esterase and cholesterol oxidase or ii) cholesterol esterase, oxidized coenzyme and cholesterol dehydrogenase in an aqueous medium comprising a specific nitrogen-containing surfactant having the structure of amine or ammonium salt and a polyanion, and measuring the formed hydrogen peroxide or reduced coenzyme.